Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-08 06:07 am Purchase | 2022-12-31 | 13G | Histogen Inc. HSTO | Mitchell P. Kopin | 240,375 5.300% | 240,375 (New Position) | Filing History |
| 2023-02-08 06:07 am Purchase | 2022-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Mitchell P. Kopin | 19,197 9.000% | 19,197 (New Position) | Filing History |
| 2023-02-08 06:07 am Purchase | 2022-12-31 | 13G | Hoth Therapeutics, Inc. HOTH | Mitchell P. Kopin | 57,008 4.200% | 57,008 (New Position) | Filing History |
| 2023-02-08 06:06 am Sale | 2022-12-31 | 13G | Agile Therapeutics, Inc. AGRX | Mitchell P. Kopin | 54,600 6.300% | -14,007 (-20.42%) | Filing History |
| 2023-02-08 06:06 am Sale | 2022-12-31 | 13G | Helius Medical Technologies, Inc. HSDT | Mitchell P. Kopin | 40 5.100% | -27 (-40.00%) | Filing History |
| 2023-02-08 06:06 am Purchase | 2022-12-31 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 916 9.400% | 916 (New Position) | Filing History |
| 2023-02-08 06:06 am Purchase | 2022-12-31 | 13G | Baudax Bio, Inc. BXRXQ | Mitchell P. Kopin | 27,092 5.100% | 27,092 (New Position) | Filing History |
| 2023-02-08 06:06 am Unchanged | 2022-12-31 | 13G | Guardion Health Sciences, Inc. GHSI | Mitchell P. Kopin | 5,000,000 7.500% | 0 (Unchanged) | Filing History |
| 2023-02-08 06:05 am Purchase | 2022-12-31 | 13G | Synaptogenix, Inc. SNPX | Mitchell P. Kopin | 31,468 9.990% | 31,468 (New Position) | Filing History |
| 2023-02-08 06:05 am Purchase | 2022-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB | Mitchell P. Kopin | 1,918,959 9.990% | 687,477 (+55.83%) | Filing History |
| 2023-02-08 06:05 am Purchase | 2022-12-31 | 13G | Antelope Enterprise Holdings Limited AEHL | Mitchell P. Kopin | 540 9.990% | 227 (+72.64%) | Filing History |
| 2023-02-08 06:05 am Purchase | 2022-12-31 | 13G | Palisade Bio, Inc. PALI | Mitchell P. Kopin | 8,739 5.700% | 8,739 (New Position) | Filing History |
| 2023-02-08 06:05 am Purchase | 2022-12-31 | 13G | Aditxt, Inc. ADTX | Mitchell P. Kopin | 1 5.800% | 0 (+1.38%) | Filing |
| 2022-12-09 08:20 am Purchase | 2022-11-30 | 13G | WiSA Technologies, Inc. WISA | Mitchell P. Kopin | 236 4.990% | 209 (+775.30%) | Filing History |
| 2022-10-17 06:01 am Purchase | 2022-10-11 | 13G | Avenue Therapeutics, Inc. ATXI | Mitchell P. Kopin | 2,891 4.990% | 2,891 (New Position) | Filing History |
| 2022-09-26 06:20 am Purchase | 2022-09-16 | 13G | Aditxt, Inc. ADTX | Mitchell P. Kopin | 1 9.990% | 1 (New Position) | Filing |
| 2022-09-06 06:13 am Purchase | 2022-08-29 | 13G | Baudax Bio, Inc. BXRX | Mitchell P. Kopin | 27,291 6.500% | 16,697 (+157.60%) | Filing History |
| 2022-08-22 06:02 am Purchase | 2022-08-12 | 13G | Performance Shipping Inc. PSHG | Mitchell P. Kopin | 361,484 8.400% | 265,641 (+277.16%) | Filing History |
| 2022-08-22 06:01 am Purchase | 2022-08-16 | 13G | Palisade Bio, Inc. PALI | Mitchell P. Kopin | 10,137 9.990% | 9,876 (+3776.20%) | Filing History |
| 2022-08-15 06:01 am Purchase | 2022-08-04 | 13G | Timber Pharmaceuticals, Inc. TMBR | Mitchell P. Kopin | 115,272 4.200% | 115,272 (New Position) | Filing History |